Beta HCG, Plasma (Tumor Marker)
Tests:Beta HCG, Plasma (Tumor Marker)
Overview | |
|---|---|
| Department | Biochemistry |
| Test Code | |
| Synonyms | Tumour Marker - BHCG
HCG - tumour marker BHCG - tumour marker Human Beta chorionic gonadotrophin |
| Turnaround Time | 1 – 2 hours |
| Stability – Add test | |
Specimen Requirements | |
| Specimen Type | 7 mL plain red-top or 5 mL Li-Hep green-top |
| Specimen Transportation | |
| Preferred | |
| Pediatric Requirements | Blood 200 µL Heparinised or Plain. |
Aliquot Requirements | |
| Sample Type | |
| Minimum Volume | 200 µL Serum or Li Heparin Plasma |
| Aliquot Transportation | |
Clinical Information | |
| Reference Intervals | Reference Range 0-5 IU/L (non pregnant adult) |
| Test Method | CMIA method. Abbott i2000 Architect analyser, Abbott reagents |
| Advanced Notice | Not Required |
| Patient Preparation | Not Required |
Comments | |
| HCG test is not suitable for the primary diagnosis of malignancy. If HCG level is not consistent with the clinical status, results should be confirmed by an alternative method, which may include qualitative urine testing.
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | |